.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Queensland Health
Novartis
US Department of Justice
Merck
Fuji
Healthtrust
AstraZeneca
Federal Trade Commission
Boehringer Ingelheim

Generated: November 21, 2017

DrugPatentWatch Database Preview

GEODON Drug Profile

« Back to Dashboard

Which patents cover Geodon, and when can generic versions of Geodon launch?

Geodon is a drug marketed by Pfizer and Pfizer Inc and is included in three NDAs. There are six patents protecting this drug and one Paragraph IV challenge.

This drug has two hundred and forty-four patent family members in fifty-four countries and two supplementary protection certificates in one country.

The generic ingredient in GEODON is ziprasidone hydrochloride. There are twenty-one drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the ziprasidone hydrochloride profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
GEODON
ziprasidone mesylate
INJECTABLE;INTRAMUSCULAR020919-001Jun 21, 2002RXYesYes► Subscribe► Subscribe ► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-002Feb 5, 2001ABRXYesNo► Subscribe► SubscribeY ► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-001Feb 5, 2001ABRXYesYes► Subscribe► Subscribe ► Subscribe
Pfizer Inc
GEODON
ziprasidone hydrochloride
SUSPENSION;ORAL021483-001Mar 29, 2006DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-003Feb 5, 2001ABRXYesNo► Subscribe► Subscribe ► Subscribe
Pfizer Inc
GEODON
ziprasidone hydrochloride
SUSPENSION;ORAL021483-001Mar 29, 2006DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Pfizer
GEODON
ziprasidone mesylate
INJECTABLE;INTRAMUSCULAR020919-001Jun 21, 2002RXYesYes► Subscribe► Subscribe ► Subscribe
Pfizer
GEODON
ziprasidone mesylate
INJECTABLE;INTRAMUSCULAR020919-001Jun 21, 2002RXYesYes► Subscribe► Subscribe ► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-002Feb 5, 2001ABRXYesNo► Subscribe► Subscribe ► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-001Feb 5, 2001ABRXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: GEODON

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Inc
GEODON
ziprasidone hydrochloride
SUSPENSION;ORAL021483-001Mar 29, 2006► Subscribe► Subscribe
Pfizer
GEODON
ziprasidone mesylate
INJECTABLE;INTRAMUSCULAR020919-001Jun 21, 2002► Subscribe► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-001Feb 5, 2001► Subscribe► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-004Feb 5, 2001► Subscribe► Subscribe
Pfizer
GEODON
ziprasidone mesylate
INJECTABLE;INTRAMUSCULAR020919-001Jun 21, 2002► Subscribe► Subscribe
Pfizer
GEODON
ziprasidone mesylate
INJECTABLE;INTRAMUSCULAR020919-001Jun 21, 2002► Subscribe► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-001Feb 5, 2001► Subscribe► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-002Feb 5, 2001► Subscribe► Subscribe
Pfizer Inc
GEODON
ziprasidone hydrochloride
SUSPENSION;ORAL021483-001Mar 29, 2006► Subscribe► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-002Feb 5, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for GEODON

Drugname Dosage Strength RLD Submissiondate
ziprasidone hydrochlorideCapsules20 mg, 40 mg, 60 mg and 80 mgGeodon2/7/2005

International Patent Family for Tradename: GEODON

Country Document Number Estimated Expiration
Iceland2301► Subscribe
Colombia5070579► Subscribe
New Zealand333436► Subscribe
Argentina022643► Subscribe
CroatiaP970237► Subscribe
Canada2371550► Subscribe
Costa Rica6506► Subscribe
Panama8495801► Subscribe
China1216923► Subscribe
Czech Republic297847► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: GEODON

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2003004Lithuania► SubscribePRODUCT NAME: ZIPRASIDONUM (5-(2-(4-(1,2-BENZIZOTIAZOL-3-IL)-1-PIPERAZINIL)ETIL)-6-CHLOR-1,3-DIHIDRO-2H-INDOL-2-ONAS); REGISTRATION NO/DATE: 02/7887/8 20021002
2003004,C0904273Lithuania► SubscribePRODUCT NAME: ZIPRASIDONUM (5-(2-(4-(1,2-BENZIZOTIAZOL-3-IL)-1-PIPERAZINIL)ETIL)-6-CHLOR-1,3-DIHIDRO-2H-INDOL-2-ONAS); REGISTRATION NO/DATE: 02/7887/8 20021002
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Citi
Cipla
Colorcon
Merck
Argus Health
Chinese Patent Office
Moodys
Boehringer Ingelheim
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot